Related Experiment Video
Updated: Aug 25, 2025

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
Published on: February 26, 2018
Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure
Uma Shankar Gautam1, Rosemarie Asrican1, Gregory D Sempowski1,2
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America.
Abstract:
Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that forms aggregates (clumps) on solid agar plates and in liquid media. Detergents such as Tween 80/Tyloxapol are considered the gold standard to disrupt clump formation in Mtb cultures. The presence of detergent, however, may generate foam and hinder Mtb aerosolization thus requiring addition of an antifoam agent for optimal Mtb aerosol-based procedures. Aerosol inhalation can be technically challenging, in particular to achieve a reproducible inhaled target dose. In this study, the impact of an antifoam, the silicon antifoaming agent (SAF), on Mtb aerosolization and whole-body mouse aerosol infection was investigated. A comparative study using SAF in a liquid suspension containing Mycobacterium bovis BCG (M. bovis BCG) or Mtb H37Rv did not cause any adverse effect on bacterial viability. Incorporation of SAF during mycobacteria inhalation procedures revealed that aerosolized mycobacterial strains were maintained under controlled environmental conditions such as humidity, temperature, pressure, and airflow inside the aerosol chamber. In addition, environmental factors and spray factors were not affected by the presence of SAF in mycobacterial cultures during aerosolization. Spray factor was significantly less during aerosol procedures with a low-input dose of mycobacteria in comparison to high-dose, as predicted. The mycobacterial load recovered in the biosampler (AGI) was ~2-3 logs lower than nebulizer or input bacterial load. A consistent Mtb bacillary load determined in mouse lungs indicates that SAF does not affect mycobacteria aerosolization during the aerosol generation process. These data confirmed that 1) SAF prevents formation of excessive foam during aerosolization, 2) SAF had no negative impact on mycobacterial viability within aerosol droplets, 3) Mtb droplets within aerosol-generated particles are well within the range required for reaching and depositing deep into lung tissue, and 4) SAF had no negative impact on achieving a target dose in mice exposed to Mtb aerosol.
Insights
Silicon antifoaming agent (SAF) prevents foam during Mycobacterium tuberculosis (Mtb) aerosolization without affecting bacterial viability or lung deposition in mice. This ensures reproducible Mtb aerosol infection models.
Area of Science:
- Microbiology
- Infectious Diseases
- Aerosol Science
Background:
- Mycobacterium tuberculosis (Mtb) forms aggregates, necessitating detergents like Tween 80/Tyloxapol for culture disruption.
- Detergents can cause foaming, complicating Mtb aerosolization and requiring antifoam agents for reproducible aerosol-based procedures.
- Achieving a reproducible inhaled dose in aerosol inhalation studies is technically challenging.
Purpose of the Study:
- To investigate the impact of a silicon antifoaming agent (SAF) on Mtb aerosolization and whole-body mouse aerosol infection.
- To assess the effect of SAF on Mycobacterium bovis BCG (M. bovis BCG) and Mtb H37Rv viability.
- To evaluate the influence of SAF on aerosol generation parameters and Mtb deposition in mouse lungs.
Main Methods:
- Comparative study of SAF in liquid cultures of M. bovis BCG and Mtb H37Rv.
- Assessment of bacterial viability post-SAF incorporation.
- Evaluation of aerosolization parameters (humidity, temperature, pressure, airflow, spray factor) and Mtb load in biosamplers and mouse lungs.
Main Results:
- SAF did not adversely affect M. bovis BCG or Mtb H37Rv viability.
- SAF prevented excessive foam formation during aerosolization without altering environmental or spray factors.
- SAF did not negatively impact Mtb aerosolization, bacterial viability within droplets, particle size for lung deposition, or target dose achievement in mice.
Conclusions:
- Silicon antifoaming agent (SAF) is effective in preventing foam during Mtb aerosolization.
- SAF is compatible with Mtb cultures, maintaining bacterial viability and enabling controlled aerosol generation.
- SAF facilitates reproducible Mtb aerosol infection models in mice by ensuring consistent delivery and deposition.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017